Imunon, Inc. Finite-Lived Patents, Gross
Imunon, Inc. (IMNN) had Finite-Lived Patents, Gross of $75.00 thousand as of 2016-12-31, per its 10-K filed 2018-03-27.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedPatentsGross · last filed 2018-03-27
- 2016-12-31: Finite-Lived Patents, Gross $75.00K.
- 2015-12-31: Finite-Lived Patents, Gross $63.13K.
- 2014-12-31: Finite-Lived Patents, Gross $63.13K.
- 2013-12-31: Finite-Lived Patents, Gross $63.13K.
| Period end | Finite-Lived Patents, Gross |
|---|---|
| 2016-12-31 | $75.00K 10-K · filed 2018-03-27 |
| 2015-12-31 | $63.13K 10-K · filed 2016-03-30 |
| 2014-12-31 | $63.13K 10-K · filed 2015-03-12 |
| 2013-12-31 | $63.13K 10-K · filed 2014-03-13 |
| 2012-12-31 | $73.13K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |